Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 369-374

  Rodríguez Carmona, Ana ^a   Pérez Fontán, Miguel ^a   Guitián, Ana ^a   Peteiro, Javier ^a   García Falcón, Teresa ^a   López Muñiz, Andrés ^a   García Buela, Jesús ^a   Cordido, Fernando ^a,b  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

adipokines; appetite; biocompatible solutions; gut peptides; malnutrition; peritoneal dialysis

Indexed keywords

ADIPONECTIN; CHOLECYSTOKININ; CYTOKINE; DIANEAL; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GROWTH HORMONE; LEPTIN; LOW GLUCOSE DEGRADATION PRODUCT LACTATE BUFFERED PERITONEAL DIALYSIS SOLUTION; PEPTIDE YY; PERITONEAL DIALYSIS FLUID; UNCLASSIFIED DRUG;

ADULT; AGED; APPETITE; ARTICLE; BICARBONATE BLOOD LEVEL; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; CYTOKINE RELEASE; FEMALE; HUMAN; LACTATE BLOOD LEVEL; MALE; OVERALL SURVIVAL; PERITONEAL DIALYSIS; PERITONEAL FLUID; PH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; UREA BLOOD LEVEL;

ADIPOKINES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BICARBONATES; BUFFERS; CREATININE; CROSS-SECTIONAL STUDIES; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; GHRELIN; HUMANS; INTESTINES; LACTATES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PERITONEAL DIALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84856644182     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr244     Document Type: Article

References (36)

1. Mortier S, Faict D, Lameire NH, de Vriese AS. Benefits of swtiching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005; 67: 1559-1565 (Pubitemid 40463136)
2. Szeto CC, Chow KM, Lam CW et al. Clinical biocompatibility of neutral peritoneal dialysis solution with minimal glucose-degradation-products-a 1 year randomized controlled trial. Nephrol Dial Transplant 2007; 22: 552-559 (Pubitemid 46189901)
3. Bajo MA, Pérez-Lozano ML, Albar-Vizcaino P et al. Low-GDP peritoneal dialysis fluid has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant 2011; 26: 282-291
4. Hekking LH, Zareie M, Driesprong BA et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to bicarbonate/lactate-buffered solutions. J Am Soc Nephrol 2001; 12: 2775-2786 (Pubitemid 33115426)
5. Fan SL, Pile T, Punzalan S et al. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008; 73: 200-206
6. Kim S, Oh J, Kim S et al. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study. Nephrol Dial Transplant 2009; 24: 2899-2908
7. Haag-Weber M, Kramer R, Haake R et al. Low-GDP fluid (Gambro-sol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant 2010; 25: 2288-2296
8. Han SH, Ahn SV, Yun JY et al. Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions. Am J Kidney Dis 2009; 54: 711-720
9. Bossola M, Tazza L, Giungi S et al. Anorexia in hemodialysis patients: an update. Kidney Int 2006; 70: 417-422 (Pubitemid 44141567)
10. Teta D, Tedjani A, Burnier M et al. Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes. Nephrol Dial Transplant 2005; 20: 1329-1335 (Pubitemid 41430606)
11. Pérez Fontán M, Cordido F, Rodríguez-Carmona A et al. Acute plasma ghrelin and leptin responses to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 2005; 68: 2877-2885 (Pubitemid 43251035)
12. Furuya R, Odamaki M, Kumagai H et al. Beneficial effects of icodextrin on plasma levels of adipocytokines in peritoneal dialysis patients. Nephrol Dial Transplant 2006; 21: 494-498 (Pubitemid 43160008)
13. Fang W, Mullan R, Shah H et al. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single dwell study. Perit Dial Int 2008; 28: 35-43 (Pubitemid 351566124)
14. Choi HY, Kim DK, Lee TH et al. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int 2008; 28: 174-182 (Pubitemid 351552402)
15. Pajek J, Kveder R, Bren A et al. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study. Nephrol Dial Transplant 2009; 24: 1617-1625
16. Simonsen O, Sterner G, Carlsson O et al. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture. Perit Dial Int 2006; 26: 353-359 (Pubitemid 44340004)
17. Fusshoeller A, Plail M, Grabensee B et al. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004; 19: 2101-2106 (Pubitemid 39139644)
18. Pajek J, Kveder R, Bren A et al. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int 2008; 28: 44-52 (Pubitemid 351566125)
19. Heimbürger O, Stenvinkel P. Adipokines in chronic kidney disease-fat tissue gives nephrologists a message. Perid Dial Int 2005; 25: 340-342 (Pubitemid 41136463)
20. Menon V, Li L, Wang X et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2599-2606 (Pubitemid 44300977)
21. Yoshimoto A, Mori K, Sugawara A et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748-2752 (Pubitemid 35216044)
22. Pérez Fontán M, Cordido F, Rodŕiguez-Carmona A et al. Short-term regulation of peptide YY secretion by a mixed meal or peritoneal glucose-based dialysate in patients with chronic renal failure. Nephrol Dial Transplant 2008; 26: 3696-3703
23. Aguilera A, Codoceo R, Selgas R et al. Anorexigen and orexigen plasma levels in peritoneal dialysis patients: their relation with nutritional parameters. Nephrol Dial Transplant 1998; 13: 1476-1483
24. Meier JJ, Nauck MA, Kranz D et al. Secretion, degradation and elimination of glucagon-like peptide 1 and gastric inhibitory polypep-tide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 2004; 53: 654-662 (Pubitemid 38270634)
25. Suneja M, Murry DJ, Stokes JB et al. Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes. Am J Physiol Endocrinol Metab 2010; 300: E55-E64
26. Stenvinkel P, Lindholm B, Lonnqvist F et al. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000; 11: 1303-1309 (Pubitemid 30416227)
27. Wright M, Woodrow G, O'Brien S et al. Cholecystokinin and leptin: their influence upon the eating behaviour and nutrient intake of dialysis patients. Nephrol Dial Transplant 2004; 19: 133-140 (Pubitemid 38072624)
28. Pe'rez Fonta'n M, Rodr'guez-Carmona A, Cordido F et al. Hyper-leptinemia in uremic patients undergoing conservative management, periperitoneal dialysis and hemodialysis: a comparative analysis. Am J Kidney Dis 1999; 34: 824-831 (Pubitemid 29521697)
29. Teta D, Maillard M, Halabi G et al. The leptin/adiponectin ratio: potential implications for peritoneal dialysis. Kidney Int 2008; 73: S112-S118 (Pubitemid 351466527)
30. Heimbürger O, Wang T, Lönqvist F et al. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Neph-rol Dial Transplant 1999; 14: 723-727 (Pubitemid 29106006)
31. Chang CC, Hung CH, Chen HL et al. Peritoneal transport characteristics and dwelling time significantly impact ghrelin clearance in peritoneal dialysis patients. Nephrol Dial Transplant 2007; 22: 224-228
32. Teta D, Maillard M, Tedjani A et al. The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes. Nephrol Dial Transplant 2007; 22: 862-869 (Pubitemid 46351698)
33. Zheng ZH, Sederholm F, Anderstam B et al. Acute effects of peritoneal dialysis solutions on appetite in uremic rats. Kidney Int 2001; 60: 2392-2398 (Pubitemid 33070484)
34. Zheng ZH, Anderstam B, Yu X et al. Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behaviour than lactate-based peritoneal dialysis solution. Perit Dial Int 2009; 29: 656-663
35. Nass R, Farthy LS, Liu J et al. Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. J Clin Endocrinol Metab 2008; 93: 1988-1994 (Pubitemid 351656548)
36. Disthabanchong S, Niticharoenpong K, Radinahamed W et al. Metabolic acidosis lowers circulating adiponectin through inhibition of adiponectin gene transcription. Nephrol Dial Transplant 2011; 26: 592-598